PleoPharma: Latest News, Top Stories & Analysis

PleoPharma Secures Key Patents for Cannabis Withdrawal Treatment

October 13, 2024October 12, 2024 - by Timothy Alexander

PHOENIXVILLE, PA — PleoPharma, Inc. has announced the issuance of two critical U.S. patents that bolster its efforts to treat cannabis withdrawal syndrome (CWS). These patents, U.S. Patent 11,197,846 and U.S. …

Research

PleoPharma’s PP-01 Shows Promise in Treating Cannabis Withdrawal Syndrome

September 9, 2024September 9, 2024 - by Timothy Alexander

PHOENIXVILLE, PA — PleoPharma, Inc. has announced promising results from a Phase 2b study evaluating its leading drug candidate, PP-01, intended for mitigating Cannabis Withdrawal Syndrome. Conducted across 22 US addiction …